KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biogen (BIIB) Exchange Rate Effect (2016 - 2025)

Biogen (BIIB) has 17 years of Exchange Rate Effect data on record, last reported at $2.5 million in Q4 2025.

  • For Q4 2025, Exchange Rate Effect rose 103.36% year-over-year to $2.5 million; the TTM value through Dec 2025 reached $101.9 million, up 250.52%, while the annual FY2025 figure was $101.9 million, 250.52% up from the prior year.
  • Exchange Rate Effect reached $2.5 million in Q4 2025 per BIIB's latest filing, up from -$3.2 million in the prior quarter.
  • Across five years, Exchange Rate Effect topped out at $68.3 million in Q2 2025 and bottomed at -$74.4 million in Q4 2024.
  • Average Exchange Rate Effect over 5 years is -$2.3 million, with a median of -$6.8 million recorded in 2022.
  • Peak YoY movement for Exchange Rate Effect: tumbled 525.0% in 2022, then soared 642.06% in 2025.
  • A 5-year view of Exchange Rate Effect shows it stood at -$15.8 million in 2021, then surged by 525.32% to $67.2 million in 2022, then dropped by 28.72% to $47.9 million in 2023, then tumbled by 255.32% to -$74.4 million in 2024, then surged by 103.36% to $2.5 million in 2025.
  • Per Business Quant database, its latest 3 readings for Exchange Rate Effect were $2.5 million in Q4 2025, -$3.2 million in Q3 2025, and $68.3 million in Q2 2025.